Silk Road Medical to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
Silk Road Medical (NASDAQ: SILK) announced plans to release its financial results for Q4 and the full year 2022 on February 28, 2023, after market close. Following this, management will host an audio webcast at 1:30 PM PT / 4:30 PM ET. The company specializes in reducing stroke risks through its innovative TransCarotid Artery Revascularization (TCAR) procedure, which combines surgical neuroprotection principles with minimally invasive techniques. Interested participants can register online for the conference call. For further details, visit Silk Road Medical's investor relations page.
- None.
- None.
SUNNYVALE, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the fourth quarter and full year 2022 after market close on Tuesday, February 28th, 2023. Company management will host a corresponding audio webcast beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Those interested in listening to the conference call should register online using this link. Participants are encouraged to register more than 15 minutes before the start of the call. A live and replay version of the webcast will be available at https://investors.silkroadmed.com.
About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.
Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
investors@silkroadmed.com
FAQ
When will Silk Road Medical report its Q4 2022 financial results?
What is the purpose of the audio webcast scheduled by Silk Road Medical?
What innovative procedure does Silk Road Medical specialize in?
What time will the Silk Road Medical audio webcast begin?
